Quince Therapeutics, Inc.
QNCX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $6 | $17 | $8 | $6 |
| Short-Term Investments | $20 | $18 | $24 | $35 |
| Receivables | $0 | $1 | $1 | $1 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $3 | $2 | $1 | $2 |
| Total Curr. Assets | $29 | $37 | $34 | $44 |
| Property Plant & Equip (Net) | $1 | $1 | $1 | $1 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $68 | $68 | $62 | $60 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $12 | $11 | $10 | $10 |
| Total NC Assets | $81 | $80 | $73 | $70 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $110 | $117 | $107 | $114 |
| Liabilities | – | – | – | – |
| Payables | $3 | $2 | $3 | $3 |
| Short-Term Debt | $18 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $5 | $6 | $5 | $4 |
| Total Curr. Liab. | $26 | $7 | $8 | $7 |
| LT Debt | $0 | $17 | $16 | $15 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $6 | $6 | $5 | $5 |
| Other NC Liab. | $77 | $75 | $59 | $57 |
| Total NC Liab. | $83 | $98 | $80 | $77 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $109 | $105 | $89 | $84 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$421 | -$408 | -$392 | -$376 |
| AOCI | $6 | $6 | $2 | -$0 |
| Other Equity | $416 | $413 | $408 | $407 |
| Total Equity | $1 | $12 | $19 | $30 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $110 | $117 | $107 | $114 |
| Net Debt | $12 | $1 | $8 | $9 |